Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
Low-cost, refrigerator-stable COVID-19 vaccines will facilitate global access and improve vaccine coverage in low- and middle-income countries. To this end, subunit-based approaches targeting the receptor-binding domain (RBD) of SARS-CoV-2 Spike protein remain attractive. Antibodies against RBD neut...
Saved in:
Main Authors: | Sakshi Bajoria (Author), Kawaljit Kaur (Author), Ozan S. Kumru (Author), Greta Van Slyke (Author), Jennifer Doering (Author), Hayley Novak (Author), Sergio A. Rodriguez Aponte (Author), Neil C. Dalvie (Author), Christopher A. Naranjo (Author), Ryan S. Johnston (Author), Judith Maxwell Silverman (Author), Harry Kleanthous (Author), J. Christopher Love (Author), Nicholas J. Mantis (Author), Sangeeta B. Joshi (Author), David B. Volkin (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor-binding domain (RBD)
by: Ozan S. Kumru, et al.
Published: (2023) -
Characteristic of K3 (CpG-ODN) as a Transcutaneous Vaccine Formulation Adjuvant
by: Sayami Ito, et al.
Published: (2020) -
Clinical development of SpikoGen®, an Advax-CpG55.2 adjuvanted recombinant spike protein vaccine
by: Nikolai Petrovsky
Published: (2024) -
Aluminum Adjuvants-'Back to the Future'
by: Donatello Laera, et al.
Published: (2023) -
Development of a quantitative ELISA for SARS-CoV-2 vaccine candidate, NDV-HXP-S, with CpG 1018® adjuvant
by: Marcus Estrada, et al.
Published: (2024)